| Followers | 65 |
| Posts | 27927 |
| Boards Moderated | 0 |
| Alias Born | 11/23/2016 |
Friday, September 24, 2021 6:47:54 AM
Probably the best we can do to compare $AVXL and $SAVA Cognitive efficacy distribution, but close to completely useless due trial design, endpoint and scoring as well as data presentation differences.
What we can see is that the $SAVA ADAS-Cog scores over time are all over the place with no clear trend based on longer dosing.
What we can see is that the $SAVA ADAS-Cog scores over time are all over the place with no clear trend based on longer dosing.
